Data-sharing and re-analysis for main studies assessed by the European Medicines Agency—a cross-sectional study on European Public Assessment Reports

BACKGROUND: Transparency and reproducibility are expected to be normative practices in clinical trials used for decision-making on marketing authorisations for new medicines. This registered report introduces a cross-sectional study aiming to assess inferential reproducibility for main trials assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Siebert, Maximilian, Gaba, Jeanne, Renault, Alain, Laviolle, Bruno, Locher, Clara, Moher, David, Naudet, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Registered Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119701/
https://www.ncbi.nlm.nih.gov/pubmed/35590360
http://dx.doi.org/10.1186/s12916-022-02377-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119701/
https://www.ncbi.nlm.nih.gov/pubmed/35590360
http://dx.doi.org/10.1186/s12916-022-02377-2

Ejemplares similares